NCT00434447 - Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2009

Conditions

Bone Neoplasms

Interventions

DRUG

Zoledronic acid

Trial Locations (10)

Novartis Investigative Site, Canberra

Novartis Investigative Site, Concord

Novartis Investigative Site, Liverpool

Novartis Investigative Site, Wagga Wagga

Novartis Investigative Site, Redcliffe

Novartis Investigative Site, Townsville

Novartis Investigative Site, Woolloongabba

Novartis Investigative Site, Ballarat

Novartis Investigative Site, Box Hill

Novartis Investigative Site, Frankston